1584121-99-2
1584121-99-2
Chemical Structure
IT-901
- CAS No.: 1584121-99-2
- Formula:C17H14N2O4S
- Molecular Weight:342.37
IUPAC Name: 5-((2,4-dimethoxynaphthalen-1-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
InChIKey: JHOPCCOYRKEHQU-UHFFFAOYSA-N
SMILES: O=C(/C(C(N1)=O)=C\C2=C3C=CC=CC3=C(OC)C=C2OC)NC1=S
Biological Activity: IT-901 is an orally active and potent NF-κB subunit c-Rel inhibitor with an IC50 of 0.1 μM, 3 μM for NF-κB DNA binding and c-Rel DNA binding, respectively. IT-901, a bioactive naphthalenethiobarbiturate derivative, has the potential for human lymphoid tumors and ameliorate graft-versus-host disease (GVHD)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
IT-901 | 99.32% | IT-901 is an orally active and potent NF-κB subunit c-Rel inhibitor with an IC50 of 0.1 μM, 3 μM for NF-κB DNA binding and c-Rel DNA binding, respectively. IT-901, a bioactive naphthalenethiobarbiturate derivative, has the potential for human lymphoid tumors and ameliorate graft-versus-host disease (GVHD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.70
HY-136713Sirt1/2-IN-5 -
Similarity Score 0.63
HY-168468SKLB102 -
Similarity Score 0.59
HY-149349MtUng-IN-1 -
Similarity Score 0.58
HY-48241WAY-616296 -
Similarity Score 0.57
HY-141805MHY-1685 -
Similarity Score 0.57
HY-18669ML346 -
Similarity Score 0.57
HY-176996Ape1/Ref-1 redox-IN-1 -
Similarity Score 0.57
HY-N17905Plicatol A -
Similarity Score 0.57
HY-N17891Loddigesiinol A -
Explore the MedChemAI to find more analogs
References
- [1]. Shono Y, et al. Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in HematologicMalignancies by Blocking NF-κB-Controlled Oxidative Stress Responses. Cancer Res. 2016 Jan 15;76(2):377-89. [Content Brief]
- [2]. Vaisitti T, et al. Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cellsby a novel NF-κB inhibitor. Haematologica. 2017 Nov;102(11):1878-1889. [Content Brief]
